These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38227712)

  • 1. Pathogenic Variants of Scavenger Receptor
    Canavati C; Siam A; Labes S; Trabelsi N; Regev E; Parnasa E; Barhoum B; Magadle N; Perzon O; Braun M; Mor-Shaked H; Schueler-Furman O; Tabach Y; Mevorach D
    Circulation; 2024 Jan; 149(3):270-273. PubMed ID: 38227712
    [No Abstract]   [Full Text] [Related]  

  • 2. Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech).
    Lin W; Yip ACL; Evangelista LKM; Wong RCC; Tan HC; Lim TW; Singh D
    Pacing Clin Electrophysiol; 2022 Sep; 45(9):1097-1100. PubMed ID: 35306680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
    Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
    Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-COVID mRNA vaccine myocarditis in children: report of two cases.
    Shamekh A; Powell C; Ashabani A; Abdelgadir IS
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36442910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Identified Case of Fatal Fulminant Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Necrotizing Hypersensitivity Reaction Different to Hypersensitivity or Drug-Induced Myocarditis.
    Kounis NG; Koniari I; Mplani V; Plotas P; Tsigkas G
    J Clin Immunol; 2022 May; 42(4):736-737. PubMed ID: 35178640
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocarditis after BNT162b2 vaccination in a healthy male.
    Watkins K; Griffin G; Septaric K; Simon EL
    Am J Emerg Med; 2021 Dec; 50():815.e1-815.e2. PubMed ID: 34229940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Wong HL; Hu M; Zhou CK; Lloyd PC; Amend KL; Beachler DC; Secora A; McMahill-Walraven CN; Lu Y; Wu Y; Ogilvie RP; Reich C; Djibo DA; Wan Z; Seeger JD; Akhtar S; Jiao Y; Chillarige Y; Do R; Hornberger J; Obidi J; Forshee R; Shoaibi A; Anderson SA
    Lancet; 2022 Jun; 399(10342):2191-2199. PubMed ID: 35691322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
    Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
    JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
    Mevorach D; Anis E; Cedar N; Bromberg M; Haas EJ; Nadir E; Olsha-Castell S; Arad D; Hasin T; Levi N; Asleh R; Amir O; Meir K; Cohen D; Dichtiar R; Novick D; Hershkovitz Y; Dagan R; Leitersdorf I; Ben-Ami R; Miskin I; Saliba W; Muhsen K; Levi Y; Green MS; Keinan-Boker L; Alroy-Preis S
    N Engl J Med; 2021 Dec; 385(23):2140-2149. PubMed ID: 34614328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyolysis after BNT162b2 mRNA Covid-19 vaccine in an adolescent male.
    Sutcu M; Gul D; Atik F; Kara M
    Malawi Med J; 2022 Jun; 34(2):154-156. PubMed ID: 35991822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA binding-groove motifs are associated with myocarditis induction after Pfizer-BioNTech BNT162b2 vaccination.
    Aharon A; Benedek G; Barhoum B; Parnasa E; Magadle N; Perzon O; Mevorach D
    Eur J Clin Invest; 2024 Apr; 54(4):e14142. PubMed ID: 38071404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.
    Buchan SA; Alley S; Seo CY; Johnson C; Kwong JC; Nasreen S; Thampi N; Lu D; Harris TM; Calzavara A; Wilson SE
    JAMA Pediatr; 2023 Apr; 177(4):410-418. PubMed ID: 36848096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.
    Witberg G; Magen O; Hoss S; Talmor-Barkan Y; Richter I; Wiessman M; Aviv Y; Grinberg T; Shiyovich A; Schamroth-Pravda N; Auster O; Dagan N; Birk E; Balicer R; Kornowski R
    N Engl J Med; 2022 Nov; 387(19):1816-1817. PubMed ID: 36260842
    [No Abstract]   [Full Text] [Related]  

  • 15. Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    Massari M; Spila Alegiani S; Morciano C; Spuri M; Marchione P; Felicetti P; Belleudi V; Poggi FR; Lazzeretti M; Ercolanoni M; Clagnan E; Bovo E; Trifirò G; Moretti U; Monaco G; Leoni O; Da Cas R; Petronzelli F; Tartaglia L; Mores N; Zanoni G; Rossi P; Samez S; Zappetti C; Marra AR; Menniti Ippolito F;
    PLoS Med; 2022 Jul; 19(7):e1004056. PubMed ID: 35900992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute monomelic radiculoplexus neuropathy following Comirnaty© (Pfizer-BioNTech COVID-19) vaccination: A case report.
    Coly M; Balcerac A; Brasseur N; Sallansonnet-Froment M; Tafani C; Taifas I; Bréchemier ML; Drouard E; Foissaud V; Vest P; Vandendries C; Bompaire F; Bihan K; Ricard D
    Rev Neurol (Paris); 2023 Jun; 179(6):636-639. PubMed ID: 36925320
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
    Oster ME; Shay DK; Su JR; Gee J; Creech CB; Broder KR; Edwards K; Soslow JH; Dendy JM; Schlaudecker E; Lang SM; Barnett ED; Ruberg FL; Smith MJ; Campbell MJ; Lopes RD; Sperling LS; Baumblatt JA; Thompson DL; Marquez PL; Strid P; Woo J; Pugsley R; Reagan-Steiner S; DeStefano F; Shimabukuro TT
    JAMA; 2022 Jan; 327(4):331-340. PubMed ID: 35076665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of cardiovascular symptoms after Pfizer-BioNTech COVID-19 vaccine in teenagers in the emergency department.
    Liao YF; Tseng WC; Wang JK; Chen YS; Chen CA; Lin MT; Lu CW; Wu MH; Chiu SN
    J Formos Med Assoc; 2023 Aug; 122(8):699-706. PubMed ID: 36564302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.
    Witberg G; Barda N; Hoss S; Richter I; Wiessman M; Aviv Y; Grinberg T; Auster O; Dagan N; Balicer RD; Kornowski R
    N Engl J Med; 2021 Dec; 385(23):2132-2139. PubMed ID: 34614329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.